ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,659.31
4.29%
S&P 500
5,129.65
1.29%
Dow Jones
38,666.20
1.15%
US Dollar vs Yen
152.949
-0.07%
Brent Oil
82.79
-1.00%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Orgenesis Inc (ORGS)

  7. Orgenesis Inc (ORGS) ニュース

ORGS Orgenesis Inc

0.5251
-0.0179 (-3.30%)
最終更新日： 03:58:37
15分遅延
名称 銘柄コード 市場 種別
Orgenesis Inc ORGS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
-0.0179 -3.30% 0.5251 03:58:37
始値 安値 高値 終値 前日終値
0.547 0.505 0.5796 0.543
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1606:07GLOBEOrgenesis Provides Year End Business Update
2024/4/1101:00GLOBEGermfree and Orgenesis Announce Asset Purchase and Strategic..
2024/3/1821:30GLOBEVered Caplan, CEO of Orgenesis, to Present at the..
2024/3/1321:30GLOBEOrgenesis Consortium Awarded €1.5M EUR Grant from the..
2024/3/0422:30GLOBEOrgenesis Inc. Announces $2.3 Million Private Placement
2024/2/2922:30GLOBEOrgenesis Consortium Awarded €2.0M EUR Grant from Walloon..
2024/1/3123:20EDGAR2Form 8-K - Current report
2024/1/3123:15GLOBEOrgenesis Acquires Control of Octomera with the Goal of..
2024/1/2506:05EDGAR2Form 8-K - Current report
2024/1/2306:01EDGAR2Form 8-K - Current report
2024/1/0907:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0907:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0520:02EDGAR2Form 8-K - Current report
2023/11/1422:30GLOBEOrgenesis Ranked No. 171st Fastest-Growing Company in North..
2023/11/1406:15GLOBEOrgenesis Provides Business Update for the Third Quarter of..
2023/11/0921:41EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/0823:24EDGAR2Form 8-K - Current report
2023/11/0823:00GLOBEOrgenesis Inc. Announces Pricing of $1.1 Million Registered..
2023/11/0221:00GLOBEOrgenesis Announces Expanded Partnership Between Octomera..
2023/10/3110:30GLOBEOrgenesis Announces Withdrawal of Proposed Public Offering
2023/10/3105:07GLOBEOrgenesis Announces Proposed Underwritten Public Offering
2023/9/2121:00GLOBECGT Global and Octomera Enter Agreement to Expand Cell &..
2023/9/0620:00GLOBECell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard..
2023/9/0605:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1120:00GLOBEOrgenesis Provides Business Update for Second Quarter of..
2023/8/1106:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1021:30GLOBEOrgenesis Schedules Second Quarter 2023 Business Update..
2023/7/1321:30GLOBEOrgenesis Appoints Finance Veteran Elliot Maltz as its Chief..
2023/7/1305:05EDGAR2Form 8-K - Current report
2023/7/1120:00GLOBEOrgenesis Announces Name Change of Morgenesis Business Unit..
2023/6/0720:00GLOBEOrgenesis and University of California, Davis Sign..
2023/5/3022:30GLOBEClaudia Zylberberg Appointed as Independent Board Member of..
2023/5/2220:30GLOBEOrgenesis Academy Graduates First Class of Cell and Gene..
2023/5/1921:30GLOBEOrgenesis to Participate in Benchmark’s 3rd Annual..
2023/5/1820:30GLOBEOrgenesis Announces Collaboration Agreement with SCTbio to..
2023/5/1105:30GLOBEOrgenesis Provides Business Update for the First Quarter of..
2023/5/1023:00GLOBEOrgenesis Secures an Additional $5 Million Investment from..

最近閲覧した銘柄

NASDAQ
ORGS
Orgenesis
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有